NCT07512466Not yet recruiting
Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
Research outcome measures: 1. Primary (main): To Evaluate the Gross Total Resection Rate Using Endoscopic Approach for Lesions Extended To Anatomically Challenging Areas 2. Secondary (subsidiary): 1. Assess postoperative improvement in Quality of Life 2. Quantify intraoperative blood loss and surgical duration 3. Document the incidence of complications (CSF leak, nerve palsy, vascular injury)
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 17 Mar 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Childhood cancers
- NCT number
- NCT07512466
What you commit to
- Study type: Interventional
- Planned participants: 25
- From 1 Apr 2026 to the primary completion date, 31 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Extensive lesions required open approach ex (intraconal extension need orbital exenteration).
- Absolute contraindications to general anaesthesia.
Who the study is looking for
- -Patients with sinonasal and nasopharyngeal tumors
Age in the registry: 1 year to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.